Stanley L. Hazen - Concepedia

Author

Stanley L. Hazen

Also Known As

A. Michael Lincoff, Daniel J Rader, Fiehn, Oliver, Gurpreet S Wander, Hazen, Stanley, Hazen, Stanley L, Hazen, Stanley L., Hooman Allayee, Jaspal S. Kooner, Kiran Garimella

754

Publications

90.2K

Citations

151

H-Index

283

Concepts

All Affiliations

Cleveland Clinic Cleveland Clinic Lerner College of Medicine Cleveland State University Case Western Reserve University Washington University in St. Louis

About

Stanley L. Hazen is an author at Cleveland Clinic specializing in medicine, biochemistry, and oxidative stress.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	80	167	36.8K
2	Health Sciences	30	33	10.3K
3	Natural Sciences	21	26	2.6K
4	Engineering	8	8	986
5	Law	1	1	32

Stanley L. Hazen

423

Publications

74.2K

Citations

134

H-Index

Page 1

	Year	Citations
Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease Zeneng Wang, Elizabeth Klipfell, Brian J. Bennett, Nature Metabolic SyndromePhysiologyLipoprotein MetabolismMetabolismMedicine	2011	5.4K
Intestinal microbiota metabolism of l-carnitine, a nutrient in red meat, promotes atherosclerosis Robert Koeth, Zeneng Wang, Bruce S. Levison, Nature Medicine NutritionNutrient PhysiologyBiochemistryRed MeatMedicine	2013	4.2K
Intestinal Microbial Metabolism of Phosphatidylcholine and Cardiovascular Risk W.H. Wilson Tang, Zeneng Wang, Bruce S. Levison, New England Journal of Medicine	2013	3.2K
Gut Microbial Metabolite TMAO Enhances Platelet Hyperreactivity and Thrombosis Risk Weifei Zhu, Jill C. Gregory, Elin Org, Cell InflammationThrombosisThrombopoiesisThrombosis RiskDysbiosis	2016	1.8K
Large-scale association analysis identifies new risk loci for coronary artery disease Panos Deloukas, Stavroula Kanoni, Christina Willenborg, Nature Genetics Genome-wide Association StudyLarge-scale Association AnalysisEpidemiologyCardiovascular EpidemiologyCardiovascular Disease	2012	1.7K
Non-lethal Inhibition of Gut Microbial Trimethylamine Production for the Treatment of Atherosclerosis Zeneng Wang, Adam Roberts, Jennifer A. Buffa, Cell DysbiosisMedicineLipid PeroxidationNon-lethal InhibitionBiotechnology	2015	1.3K
Gut Microbiota-Dependent Trimethylamine <i>N</i> -Oxide (TMAO) Pathway Contributes to Both Development of Renal Insufficiency and Mortality Risk in Chronic Kidney Disease W.H. Wilson Tang, Zeneng Wang, David J. Kennedy, Circulation Research	2014	1.1K
Targeted disruption of the class B scavenger receptor CD36 protects against atherosclerotic lesion development in mice Maria Febbraio, Eugene A. Podrez, Jonathan D. Smith, Journal of Clinical Investigation	2000	1K
Trimethylamine-N-Oxide, a Metabolite Associated with Atherosclerosis, Exhibits Complex Genetic and Dietary Regulation Brian J. Bennett, Thomas Q. de Aguiar Vallim, Zeneng Wang, Cell Metabolism Metabolic SyndromeHealth SciencesBiochemistryLipid PeroxidationPhysiology	2013	1K
3-Chlorotyrosine, a specific marker of myeloperoxidase-catalyzed oxidation, is markedly elevated in low density lipoprotein isolated from human atherosclerotic intima. Stanley L. Hazen, Jay W. Heinecke Journal of Clinical Investigation Lipid PeroxidationLow DensityReagent HoclRedox BiologyOxidative Stress	1997	842

Page 1